These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Atkinson RJ, Michie PT, Schall U. Biol Psychiatry; 2012 Jan 15; 71(2):98-104. PubMed ID: 22000060 [Abstract] [Full Text] [Related]
10. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders. Kaur M, Lagopoulos J, Lee RS, Ward PB, Naismith SL, Hickie IB, Hermens DF. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct 01; 46():161-9. PubMed ID: 23851120 [Abstract] [Full Text] [Related]
11. Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis. Murphy JR, Rawdon C, Kelleher I, Twomey D, Markey PS, Cannon M, Roche RA. BMC Psychiatry; 2013 Feb 02; 13():45. PubMed ID: 23375130 [Abstract] [Full Text] [Related]
19. The preattentive change detection in preschool children with attention deficit hyperactivity disorder: a mismatch negativity study. Zhang J, Qiu M, Pan J, Zhao L. Neuroreport; 2020 Jul 10; 31(10):776-779. PubMed ID: 32453022 [Abstract] [Full Text] [Related]